Tailored Mobile Text Messaging to Reduce Problem Drinking

Sponsor
Northwell Health (Other)
Overall Status
Completed
CT.gov ID
NCT01885312
Collaborator
National Institute on Alcohol Abuse and Alcoholism (NIAAA) (NIH)
174
1
4
30
5.8

Study Details

Study Description

Brief Summary

This study is designed to develop and test a tailored adaptive text messaging/short message service (SMS) intervention for individuals interested in stopping or reducing their alcohol consumption; and test and compare it to tailored but static, once a day messaging, gain framed messaging, and ecological momentary assessment only.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Adaptive Tailored Intervention
  • Behavioral: Consequence-based Intervention
  • Behavioral: Tailored, not adaptive, based Intervention
  • Other: Assessment only
N/A

Detailed Description

The proposed development study entitled, Tailored Mobile Text Messaging to Reduce Problem Drinking is designed to develop and test a tailored adaptive text messaging/short message service (SMS) intervention for individuals interested in stopping or reducing their alcohol consumption. This intervention includes messages tailored to baseline assessment results (including drinking times) that are adaptive to ongoing drinking patterns and goal achievement via interactive ecological momentary assessment (EMA). Other features include participant initiated help messaging and support network alerts. We will conduct beta research with 40 problem drinkers to assess messaging preferences and acceptability, and then conduct a pilot test with 10 PDs. In Stage 1b, we aim to test this intervention and understand the mechanisms of action of different text messaging interventions with 200 problem drinkers over a 12-week period. We propose to compare four types of messaging: 1) Tailored content and timed messaging adaptive to the participants current state (Stage 1a intervention); 2) Tailored content messaging (not adaptive or timed) sent at 3 pm every day; 3) Untailored consequence based messages sent at 3 pm every day; and 4) Brief feedback and EMA only. Assessments will be completed at baseline, through weekly EMA via SMS and at week 12 via a web-based follow-up assessment. Primary outcomes include drinks per drinking day, days of heavy drinking, and average drinks per week as measured through weekly EMA. Additional outcomes will include drinking related consequences, goal commitment and intervention satisfaction. Outcomes will be used to modify the intervention and to prepare for a larger Stage 1c RCT.

Study Design

Study Type:
Interventional
Actual Enrollment :
174 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Tailored Mobile Text Messaging to Reduce Problem Drinking
Study Start Date :
Feb 1, 2014
Actual Primary Completion Date :
Dec 1, 2015
Actual Study Completion Date :
Aug 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Tailored not adaptive based Intervention

Tailored Text Messaging - not adaptive in the moment and once a day intervention to reduce problem drinking

Behavioral: Tailored, not adaptive, based Intervention
Baseline tailored not adaptive

Other: Ecological Momentary Assessment

Mobile Assessment only

Other: Assessment only
EMA only

Experimental: Tailored Adaptive Text Messaging

Tailored Adaptive Text Messaging intervention to reduce problem drinking

Behavioral: Adaptive Tailored Intervention
Adaptive

Active Comparator: Consequence based text messaging

Consequence based Text Messaging intervention to reduce problem drinking

Behavioral: Consequence-based Intervention
Loss Framed

Outcome Measures

Primary Outcome Measures

  1. Days of Heavy Drinking (DHD) [12 weeks]

  2. Average Drinks per Week (ADW) [12 weeks]

Secondary Outcome Measures

  1. Drinking Related Consequences [12 weeks]

  2. Goal Commitment [12 weeks]

Other Outcome Measures

  1. Intervention Satisfaction [12 weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
Participants must:
  • be fluent and able to read in English at the eighth grade level

  • be between the ages of 21 and 65

  • have an estimated average weekly consumption of greater than 15 or 24 standard drinks per week for women and men, respectively

  • be willing to reduce their drinking to non-hazardous levels

  • be willing to provide informed consent

  • own a mobile phone and have an active email address and are willing to receive and respond to up to 115 text messages total per month (average = 50)

Exclusion Criteria:
  • Participants will be excluded from the study if they

  • present with significant substance use or a current substance use disorder (for any substance other than alcohol, nicotine, or caffeine), which is defined as greater than once weekly use in the past month

  • present with a serious psychiatric illness or suicide risk as measured by previous inpatient treatment, medications for psychosis or recent suicidality; demonstrate clinically severe alcoholism, as evidenced by physical withdrawal symptoms or a history of serious withdrawal symptoms (e.g., hallucinations, seizures, or delirium tremens), and score greater than 12 on the Short Alcohol Withdrawal Scale (SAWS)

  • express a desire or intent to obtain additional substance abuse treatment while in the study

  • report a medical condition that precludes drinking any alcohol; or

  • demonstrate cognitive impairment as evidenced a score of less than 7 out of 10 on the consent form quiz

Contacts and Locations

Locations

Site City State Country Postal Code
1 Feinstein Institute for Medical Research / North Shore-LIJ Health System Great Neck New York United States 11021

Sponsors and Collaborators

  • Northwell Health
  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Investigators

  • Principal Investigator: Fred Muench, PhD, Feinstein Institute for Medical Research / North Shore-LIJ Health System

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Northwell Health
ClinicalTrials.gov Identifier:
NCT01885312
Other Study ID Numbers:
  • AA021502-2
  • 1R34AA021502-01
First Posted:
Jun 24, 2013
Last Update Posted:
Oct 13, 2016
Last Verified:
Oct 1, 2016
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Keywords provided by Northwell Health
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 13, 2016